About this trial
Software refraction in the mobilerone for myopia and astigmatism is a novel medical device for myopia adults and elder children with or without astigmatism. And the investigators would like to test its accuracy and efficacy as well as safety.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
• subject with ametropia on each eye ≤-12.00D
subject with best corrected visual acuity ≥ 20/25, no amblyopia
subject with normal transparency of eyes
subject with a healthy fundus that does not reveal major abnormalities that may affect vision due to the fluctuate situations
Disqualifiers
• subject with a topography showing an anomaly (keratoconus type or other)
subject with hyperopia or presbyopia
subject with mild myopia ≥ -1.00D
subject who cannot speak with the operator including those staff of local optometrists or ophthalmologists
Trial design
Parallel
Treatments tested in this trial
Software refraction with Eye Test Technology in a mobilerone
DeviceRefraction is done by software App by a mobilerone software installed.
Retinoscopy
DeviceRetinoscopy is an objective refraction method with retinoscope.
Treatment groups
Trial outcomes
Primary outcomes
Spherical Equivalence(D)
Spherical is myopic equivalence with total spherical plus half the cylinder diopter.
Astigmatism Power(D)
Cylinder value of each total astigmatism power
Astigmatism axial
Cylinder axis of astigmatism
pupil distance (mm)
pupil distance measurement with software or autorefractor
Secondary outcomes
Efficacy of test time (minutes)
How long for each test
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Beijing Airdoc Technology Co., Ltd.
Lead sponsor
University of Notre Dame Australia
Collaborator